標(biāo)題：
1、2015年美國(guó)CDC生殖器皰疹治療指南解讀 中國(guó)皮膚性病學(xué)雜志 2016年5月，第30卷第5期 530-3
2、Search for useful biomarkers in hepatocellular carcinoma, tumor factors and background liver factors (Review).
3、Biomarkers in hepatocellular carcinoma: an overview.
4、An economic analysis of tolvaptan compared with fluid restriction among hospitalized patients with hyponatremia.
5、Catalytic Michael/Ring-Closure Reaction of α,β-Unsaturated Pyrazoleamides with Amidomalonates: Asymmetric Synthesis of (?)-
Paroxetine
6、Kumamoto, Koji; Ichikawa, Yoshiyasu; Kotsuki, Hiyoshizo Synlett, 2005 , # 14 art. no. U13805ST, p. 2254 - 2256
7、Smith, Brendan M.; Graham, Andrew E. Tetrahedron Letters, 2006 , vol. 47, # 52 p. 9317 - 9319
8、Comparison of antiplatelet and antithrombotic therapy for secondary prevention of ischemic stroke in patients with peripheral artery
disease: population-based follow-up study in Taiwan.
Lee WH, Chu CY, Hsu PC, Su HM, Lin TH, Voon WC, Lai WT, Sheu SH.
Circ J. 2013;77(4):1046-52. Epub 2012 Dec 26.
9、Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment.
Robertson L, Ghouri MA, Kovacs F.
Cochrane Database Syst Rev. 2012 Aug 15;(8):CD002071. doi: 10.1002/14651858.CD002071.pub3. Review.
10、Drug-drug interactions associated with antiplatelet therapy.
11、H. Kreitmair, Arch. exp. Path. Pharmak. 164, 346 (1932).
12、R.D. Haworth et al., j. chem. Soc. 1947, 176
13、Tracking MET de-addiction in lung cancer: A road towards the oncogenic target.
14、Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers.
15、鹽酸伐昔洛韋顆粒劑治療兒童水痘療效觀察 中華皮膚科雜志,2009, 42(8):584-585
16、鹽酸伐昔洛韋治療兒童水痘療效觀察 中國(guó)醫(yī)師進(jìn)修雜志2011年4月25日第34卷第12期51-2
將符合標(biāo)題的文獻(xiàn)PDF格式上傳，按照交稿時(shí)間的先后確認(rèn)稿件，先到先得
[更多]
渝公網(wǎng)安備 50010802001068號(hào)
